• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 21MM NO TIP - CE; STENT, INTRACRANIAL NEUROVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 21MM NO TIP - CE; STENT, INTRACRANIAL NEUROVASCULAR Back to Search Results
Catalog Number M003EZAS40210
Device Problems Premature Activation (1484); No Visual Prompts/Feedback (4021)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/05/2023
Event Type  malfunction  
Manufacturer Narrative
The device is not available to manufacturer.
 
Event Description
It was reported that during the procedure, physician felt resistance while advancing the subject stent within the microcatheter.When the subject stent was advanced to the distal end of the microcatheter to deploy, the physician was unable to see the subject stent under fluoroscopy.The physician tried to deploy the subject stent without identifying the location of the stent.The microcatheter was then removed and it was observed that the subject stent was partially deployed within the microcatheter.The procedure was completed successfully.No clinical consequences were reported to the patient due to this event.
 
Event Description
It was reported that during the procedure, physician felt resistance while advancing the subject stent within the microcatheter.When the subject stent was advanced to the distal end of the microcatheter to deploy, the physician was unable to see the subject stent under fluoroscopy.The physician tried to deploy the subject stent without identifying the location of the stent.The microcatheter was then removed and it was observed that the subject stent was partially deployed within the microcatheter.The procedure was completed successfully.No clinical consequences were reported to the patient due to this event.
 
Manufacturer Narrative
Due to the automated manufacturing execution system (mes), there are controls in the manufacturing process to ensure the product met specifications upon release.During visual inspection, the stent was noted to be prematurely deployed within the proximal end of the microcatheter shaft and hub.The stent was noted to be extensively deformed with some fractured struts.The introducer sheath and sdw (stent delivery wire) were not returned.During functional test, the stent was removed from the microcatheter.The microcatheter was flushed and blood exited.A patency mandrel experienced friction during advancement through the microcatheter, dried blood was noted on the mandrel when it exited the microcatheter.The patency mandrel passed through the microcatheter without difficulty after the blood was cleared from microcatheter.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported events can be confirmed based on the device analysis.The device failed to meet specification when returned, based on the damage noted.It was reported sharp friction was observed when the stent was passed into the microcatheter, the resistance gave way and when the stent was raised at the distal end of the microcatheter for release, the stent was not visualized.The microcatheter was removed and it was observed that the stent was partially released at the proximal end of the microcatheter.Additional information states that the device was prepared for use as per the directions for use, continuous flush set up and maintained throughout the clinical procedure.The device was returned and the stent was noted to be prematurely deployed within the hub/proximal end of the microcatheter, confirming the reported event.The stent was removed and found to be severely deformed with fracturing to some struts.There was blood noted within the microcatheter which may have caused or contributed to the reported events.It is probable that the stent was prematurely deployed in the proximal end of the microcatheter and the microcatheter hub, during the attempt to transfer the stent into the microcatheter, when the resistance 'gave way' it is probable that the stent delivery wire was then advanced through the microcatheter, leaving the stent prematurely deployed in the proximal end of the microcatheter, hence , why the stent was unable to be visualized under fluoroscopy.An assignable cause of procedural factors will be assigned to the as reported ¿stent deployed prematurely during use¿, ¿ stent difficult/unable to advance or pullback through catheter¿ and ¿ implant not visible under fluoroscopy¿ and to the as analyzed defects, ¿stent deployed prematurely during use¿, ¿stent deformed¿ and ¿stent broken/fractured during use¿, as the issue is associated with a product that meets stryker design and manufacture specifications and was used in according with the dfu but due to procedural and/or anatomical factors during use, the product performance was limited.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROFORM ATLAS 4.0MM X 21MM NO TIP - CE
Type of Device
STENT, INTRACRANIAL NEUROVASCULAR
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key16239406
MDR Text Key308768347
Report Number3008881809-2023-00039
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P180031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberM003EZAS40210
Device Lot Number23743105
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/21/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AXS INFINITY LONG SHEATH (STRYKER); EXCELSIOR SL 10 MICROCATHETER (STRYKER); TRANSEND GUIDEWIRE (STRYKER)
Patient Age65 YR
Patient SexFemale
Patient Weight73 KG
-
-